(19)
(11) EP 3 380 520 A2

(12)

(88) Date of publication A3:
13.07.2017

(43) Date of publication:
03.10.2018 Bulletin 2018/40

(21) Application number: 16808567.8

(22) Date of filing: 22.11.2016
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
(86) International application number:
PCT/EP2016/001970
(87) International publication number:
WO 2017/088974 (01.06.2017 Gazette 2017/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 23.11.2015 US 201562258626 P
12.04.2016 EP 16164879

(71) Applicant: Merck Patent GmbH
64293 Darmstadt (DE)

(72) Inventors:
  • CELIK, Ilhan
    64673 Zwingenberg (DE)
  • STAUB, Eike
    64297 Darmstadt (DE)
  • URBAN, Miriam
    63849 Leidersbach (DE)
  • RAAB, Sabine
    61191 Rosbach (DE)
  • SAMY, Eileen
    Arlington, MA 02474 (US)
  • BENDER, Andrew
    Reading, MA 01867 (US)
  • HIGGINBOTHAM, Georgianna
    Tewksbury, MA 01876 (US)
  • WU, Yin
    Andover, MA 01810 (US)
  • XU, Daigen
    Westford, MA 01886 (US)

   


(54) ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF FIBROSIS AND/OR FIBROTIC DISORDERS